动态血压监测较诊室、家庭血压测量的优越应用价值
The Superior Application Value of Ambulatory Blood Pressure Monitoring Compared with the Blood Pressure Measurement in Office and Home
摘要: 目前,高血压已成为严重危害人类健康,影响人类生活质量,增加社会经济负担的全球性公共卫生问题之一。高血压控制不当引起的心脑血管疾病和肾脏疾病的发病率逐年增加。此外,由于高血压的起病、发生及发展的隐匿性特点导致多数高血压患者尚不清楚是否患有高血压,从而导致心脑肾脏疾病等并发症的出现,进而严重扰乱人类正常生活,影响预期寿命,并且高血压的发病逐渐呈年轻化的趋势,起病覆盖范围逐渐扩大,无论性别年龄,均有罹患高血压的可能,因此对高血压病进行及时的发现和控制刻不容缓。目前对高血压的早期诊断以及对血压的精准控制的唯一标准就是血压监测,血压监测是高血压的规范化诊断、治疗与管理过程中的重要环节,优越的血压监测方式对于提升高血压人群的血压控制率、达标率以及评估预后情况有着极大的使用和推广价值,现对诊室血压测量(office blood pressure measurement, OBPM)、家庭血压测量(home blood pressure measurement, HBPM)以及动态血压监测(ambulatory blood pressure monitoring, ABPM)的优缺点进行阐述,并重点强调动态血压监测在高血压诊治过程中的优越应用价值以期在临床推广使用。
Abstract: At present, hypertension has become one of the global public health problems that seriously endanger human health, affect the quality of human life, and increase the social and economic burden. The incidence of cardiovascular and cerebrovascular diseases and kidney diseases caused by poor hypertension control is increasing year by year. In addition, due to the insidious characteristics of the onset, occurrence and development of hypertension, most hypertensive patients are not sure whether they have hypertension, which leads to complications such as heart, brain and kidney disease, which seriously disrupts normal human life and affects expectations life expectancy, and the incidence of hypertension is gradually becoming younger, the coverage is gradually expanding, and regardless of gender and age, there is the possibility of hypertension. Therefore, timely detection and control of hypertension are urgent. At present, the only standard for early diagnosis of hypertension and precise control of blood pressure is blood pressure monitoring. Blood pressure monitoring is an important link in the standardized diagnosis, treatment and management of hypertension. The superior blood pressure monitoring method has great use and promotion value for improving the blood pressure control rate, compliance rate and prognosis assessment of hypertension people. The advantages and disadvantages of office blood pressure measurement (OBPM), home blood pressure measurement (HBPM), and ambulatory blood pressure monitoring (ABPM) are reviewed, with emphasis on the superior application value of ambulatory blood pressure monitoring in the diagnosis and treatment of hypertension to expect to be used in clinical promotion.
文章引用:张世宇, 张晓东, 邵彦铭, 于海初. 动态血压监测较诊室、家庭血压测量的优越应用价值[J]. 临床医学进展, 2021, 11(6): 2539-2546. https://doi.org/10.12677/ACM.2021.116365

参考文献

[1] Unger, T., Borghi, C., Charchar, F., et al. (2020) 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Journal of Hypertension, 38, 982-1004. [Google Scholar] [CrossRef
[2] Del Pinto, R., Dobre, M., Pagliacci, S., et al. (2020) Impact of Guidelines on Hypertension Control in the Elderly. Current Pharmaceutical Design. [Google Scholar] [CrossRef] [PubMed]
[3] 李金根, 马立永, 张立晶. 高血压诊治热点研究进展[J]. 医学综述, 2020, 26(23): 4666-4671.
[4] Luo, H., Yang, D., Barszczyk, A., et al. (2019) Smartphone-Based Blood Pressure Measurement Using Transdermal Optical Imaging Technology. Circulation Cardiovascular Imaging, 12, e008857. [Google Scholar] [CrossRef
[5] 杨旦红, 吴菁, 葛莹, 等. 高血压患者24h动态血压、随访血压与诊室血压测量结果比较[J]. 中国全科医学, 2019, 22(7): 817-821.
[6] Chan, K.K., Szeto, C.C., Lum, C.C.M., et al. (2020) Hong Kong College of Physicians Position Statement and Recommendations on the 2017 American College of Cardiology/American Heart Association and 2018 European Society of Cardiology/European Society of Hypertension Guidelines for the Management of Arterial Hypertension. Hong Kong Medical Journal, 26, 432-437. [Google Scholar] [CrossRef] [PubMed]
[7] Chang, T.I., Reboussin, D.M., Chertow, G.M., et al. (2018) Prognostic Relevance of Visit-to-Visit Office Blood Pressure Variability in Systolic Blood Pressure Intervention Trial: Same Data, Different Conclusions? The Journal of Clinical Hypertension, 20, 1644-1645. [Google Scholar] [CrossRef] [PubMed]
[8] Antza, C., Vazakidis, P., Doundoulakis, I., et al. (2020) Masked and White Coat Hypertension, the Double Trouble of Large Arteries: A Systematic Review and Meta-Analysis. The Journal of Clinical Hypertension, 22, 802-811. [Google Scholar] [CrossRef] [PubMed]
[9] 许顶立, 黄裕立. 白大衣性高血压的临床检出和处理[J]. 中华高血压杂志, 2020, 28(11): 1005-1008.
[10] Penmatsa, K.R., Biyani, M. and Gupta, A. (2020) Masked Hypertension: Lessons for the Future. The Ulster Medical Journal, 89, 77-82.
[11] Bowles, N.P., Thosar, S.S., Herzig, M.X., et al. (2018) Chronotherapy for Hypertension. Current Hypertension Reports, 20, 97. [Google Scholar] [CrossRef] [PubMed]
[12] Neldam, S., Dahlof, B., Oigman, W., et al. (2013) Early Combination Therapy with Telmisartan plus Amlodipine for Rapid Achievement of Blood Pressure Goals. International Journal of Clinical Practice, 67, 843-852. [Google Scholar] [CrossRef] [PubMed]
[13] Hermida, R.C., Smolensky, M.H., Ayala, D.E., et al. (2015) Ambulatory Blood Pressure Monitoring (ABPM) as the Reference Standard for Diagnosis of Hypertension and Assessment of Vascular Risk in Adults. Chronobiology International, 32, 1329-1342. [Google Scholar] [CrossRef] [PubMed]
[14] Mortensen, R.N., Gerds, T.A., Jeppesen, J.L., et al. (2017) Office Blood Pressure or Ambulatory Blood Pressure for the Prediction of Cardiovascular Events. European Heart Journal, 38, 3296-3304. [Google Scholar] [CrossRef] [PubMed]
[15] Vischer, A.S. and Burkard, T. (2017) Principles of Blood Pressure Measurement—Current Techniques, Office vs Ambulatory Blood Pressure Measurement. Advances in Experimental Medicine and Biology, 956, 85-96. [Google Scholar] [CrossRef] [PubMed]
[16] Ida, T., Kusaba, T., Kado, H., et al. (2019) Ambulatory Blood Pressure Monitoring-Based Analysis of Long-Term Outcomes for Kidney Disease Progression. Scientific Reports, 9, Article No. 19296. [Google Scholar] [CrossRef] [PubMed]
[17] 2019中国家庭血压监测指南[J]. 中华高血压杂志, 2019, 27(8): 708-711.
[18] Hermida, R.C., Ayala, D.E., Smolensky, M.H., et al. (2016) Chronotherapy with Conventional Blood Pressure Medications Improves Management of Hypertension and Reduces Cardiovascular and Stroke Risks. Hypertension Research: Official Journal of the Japanese Society of Hypertension, 39, 277-292. [Google Scholar] [CrossRef] [PubMed]
[19] Das, R. and Mehta, D.K. (2019) Considering Circadian Pattern of Blood Pressure in the Treatment of Hypertension via Chronotherapy: A Conducive or Maladroit Approach. Current Drug Targets, 20, 1244-1254. [Google Scholar] [CrossRef] [PubMed]
[20] Yeg, L.-G., Lnar, G., Kasap-Demir, B., Alparslan, C., et al. (2019) Ambulatory Blood Pressure Monitoring Parameters in Obese Children and Adolescents with Masked Hypertension. Blood Pressure Monitoring, 24, 277-283. [Google Scholar] [CrossRef
[21] Abdulhalim, J.K. (2017) Ambulatory Blood Pressure Monitoring in Daily Practice. Indian Heart Journal, 69, 788-789. [Google Scholar] [CrossRef] [PubMed]
[22] Marco, P., Silvia, D.M., Elisa, P., et al. (2019) Comparison of Automated Office Blood Pressure with Office and Out-Off-Office Measurement Techniques. Hypertension, 73, 481-490. [Google Scholar] [CrossRef
[23] Beyhaghi, H. and Viera, A.J. (2019) Comparative Cost-Effectiveness of Clinic, Home, or Ambulatory Blood Pressure Measurement for Hypertension Diagnosis in US Adults. Hypertension, 73, 121-131. [Google Scholar] [CrossRef
[24] Hodgkinson, J., Mant, J., Martin, U., et al. (2011) Relative Effectiveness of Clinic and Home Blood Pressure Monitoring Compared with Ambulatory Blood Pressure Monitoring in Diagnosis of Hypertension: Systematic Review. BMJ, 342, d3621. [Google Scholar] [CrossRef] [PubMed]
[25] Li, J., Li, R., Gao, Y., et al. (2019) Nocturnal Mean Arterial Pressure Rising Is Associated with Mortality in the Intensive Care Unit: A Retrospective Cohort Study. Journal of the American Heart Association, 8, e012388. [Google Scholar] [CrossRef
[26] Li, J., Cao, Y., Liu, C., et al. (2019) Nocturnal Systolic Hypertension Is a Risk Factor for Cardiac Damage in the Untreated Masked Hypertensive Patients. The Journal of Clinical Hypertension, 21, 1666-1674. [Google Scholar] [CrossRef] [PubMed]
[27] Silvani, A. (2019) Sleep Disorders, Nocturnal Blood Pressure, and Cardiovascular Risk: A Translational Perspective. Autonomic Neuroscience: Basic & Clinical, 218, 31-42. [Google Scholar] [CrossRef] [PubMed]
[28] Hermida, R.C., Ayala, D.E., Mojon, A., et al. (2011) Decreasing Sleep-Time Blood Pressure Determined by Ambulatory Monitoring Reduces Cardiovascular Risk. Journal of the American College of Cardiology, 58, 1165-1173. [Google Scholar] [CrossRef] [PubMed]
[29] Hermida, R.C., Crespo, J.J., Dominguez-Sardina, M., et al. (2019) Bedtime Hypertension Treatment Improves Cardiovascular Risk Reduction: The Hygia Chronotherapy Trial. European Heart Journal, 41, 4565-4576. [Google Scholar] [CrossRef] [PubMed]
[30] Hermida, R.C., Ayala, D.E., Mojon, A., et al. (2010) Effects of Time of Antihypertensive Treatment on Ambulatory Blood Pressure and Clinical Characteristics of Subjects with Resistant Hypertension. American Journal of Hypertension, 23, 432-439. [Google Scholar] [CrossRef] [PubMed]
[31] Moya, A., Crespo, J.J., Ayala, D.E., et al. (2013) Effects of Time-of-Day of Hypertension Treatment on Ambulatory Blood Pressure and Clinical Characteristics of Patients with Type 2 Diabetes. Chronobiology International, 30, 116-131. [Google Scholar] [CrossRef] [PubMed]
[32] Rahman, M., Greene, T., Phillips, R.A., et al. (2013) A Trial of 2 Strategies to Reduce Nocturnal Blood Pressure in Blacks with Chronic Kidney Disease. Hypertension, 61, 82-88. [Google Scholar] [CrossRef
[33] Liu, X., Liu, X., Huang, W., et al. (2014) Evening- versus Morning-Dosing Drug Therapy for Chronic Kidney Disease Patients with Hypertension: A Systematic Review. Kidney & Blood Pressure Research, 39, 427-440. [Google Scholar] [CrossRef] [PubMed]
[34] Hermida, R.C., Crespo, J.J., Otero, A., et al. (2018) Asleep Blood Pressure: Significant Prognostic Marker of Vascular Risk and Therapeutic Target for Prevention. European Heart Journal, 39, 4159-4371. [Google Scholar] [CrossRef] [PubMed]
[35] Kario, K., Kanegae, H., Tomitani, N., et al. (2019) Nighttime Blood Pressure Measured by Home Blood Pressure Monitoring as an Independent Predictor of Cardiovascular Events in General Practice. Hypertension, 73, 1240-1248. [Google Scholar] [CrossRef
[36] 王雪宁, 张慧. 原发性高血压患者动态血压监测的应用研究进展[J]. 湖北民族大学学报(医学版), 2020, 37(3): 76-79.
[37] 童慧钰. ABPM能否在心房颤动患者中应用[D]: [硕士学位论文]. 南昌: 南昌大学, 2020.
[38] Lurbe, E., Torro, I., Alvarez, J., et al. (2019) Impact of ESH and AAP Hypertension Guidelines for Children and Adolescents on Office and Ambulatory Blood Pressure-Based Classifications. Journal of Hypertension, 37, 2414-2421. [Google Scholar] [CrossRef
[39] Cheng, Y.B., Thijs, L., Zhang, Z.Y., et al. (2019) Outcome-Driven Thresholds for Ambulatory Blood Pressure Based on the New American College of Cardiology/American Heart Association Classification of Hypertension. Hypertension, 74, 776-783. [Google Scholar] [CrossRef
[40] Smolensky, M.H., Ayala, D.E. and Hermida, R.C. (2015) Ambulatory Blood Pressure Monitoring (ABPM) as the Reference Standard to Confirm Diagnosis of Hypertension in Adults: Recommendation of the 2015 U.S. Preventive Services Task Force (USPSTF). Chronobiology International, 32, 1320-1322. [Google Scholar] [CrossRef] [PubMed]
[41] 中国高血压联盟《动态血压监测指南》委员会. 2020中国动态血压监测指南[J]. 中国医学前沿杂志(电子版), 2021, 13(3): 34-51.